Hypoglycemic action of vitamin K1 protects against early-onset diabetic nephropathy in streptozotocin-induced rats

Nutrition

Volumn 31, Issue 10, 2015, Pages 1284-1292

  Sai Varsha, M K N ^a   Raman, Thiagarajan ^a   Manikandan, R ^b   Dhanasekaran, G ^b  

^a SASTRA UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

Diabetes; Diabetic nephropathy; Inflammation; Kidney; Microalbuminuria; Vitamin K

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALBUMIN; ALDEHYDE REDUCTASE; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; PHYTOMENADIONE; SUPEROXIDE DISMUTASE; UREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; MICROALBUMINURIA; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE SECTION; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; METABOLISM; OXIDATIVE STRESS; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; VITAMIN K 1; VITAMINS;

EID: 84942248274     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.05.012     Document Type: Article

References (54)

1. Suarez M.L.G., Thomas D.B., Barisoni L., Fornoni A. Diabetic nephropathy: is it time yet for routine kidney biopsy. World J Diabetes 2013, 4:245-255.
2. Koya D., Campesa V.M. Statin use in patients with diabetes and kidney disease: the Japanese experience. J Atheroscler Thromb 2013, 20:407-424.
3. Forbes J.M., Cooper M.E. Mechanism of diabetic complications. Physiol Rev 2013, 93:137-188.
4. Gorin Y., Block K. Nox as a target for diabetic complications. Clin Sci 2013, 125:361-382.
5. Heyman S.N., Rosenberger C., Seymour R., Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy. Biomed Res Int 2013, 2013:123589.
6. Morcos M., Schlotterer A., Sayed A.A., Kukudov G., Oikomonou D., Ibrahim Y., et al. Rosiglitazone reduces angiotensin II and advanced glycation end product dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. Horm Metab Res 2008, 40:752-759.
7. Al-Malki A. Oat attenuation of hyperglycemia-induced retinal oxidative stress and NF-5B activation in streptozotocininduced diabetic rats. Evid Based Complement Alternat Med 2013, 2013:983923.
8. Morcos M., Sayed A.A., Bierhaus A., Yard B., Waldherr R., Merz W., et al. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002, 51:3532-3544.
9. Myśliwska J., Zorena K., Semetkowska-Jurkiewicz E., Rachoń D., Suchanek H., Myśliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw 2005, 16:117-122.
10. McCabe K.M., Adams M.A., Holden R.M. Vitamin K status in chronic kidney disease. Nutrients 2013, 5:4390-4398.
11. McCabe K.M., Booth S.L., Fu X., Shobeiri N., Pang J.J., Adams M.A., et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013, 83:835-844.
12. Sai Varsha M.K.N., Thiagarajan R., Manikandan R., Dhanasekar G. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, inhibiting NF-kB activation and iNOS expression in rat pancreas. Nutrition 2015, 31:214-222.
13. Sai Varsha M.K.N., Thiagarajan R., Manikandan R. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis. Exp Eye Res 2014, 128:73-82.
14. Rasekhi H., Karandish M., Jalali M.-T., Mohammadshahi M., Zarei M., Saki A., et al. Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. J Diab Metab Disord 2015, 14:1-6.
15. Rees K., Guraewal S., Wong Y.L., Majanbu D.L., Mavrodaris A., Stranges S., et al. Is vitamin K consumption associated with cardio-metabolic disorders? A systematic review. Maturitas 2010, 67:121-128.
16. Nuria I.-J., Jordi S.-S., Miguel A.-G., Monica B. Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am J Clin Nutr 2012, 96:1113-1118.
17. Suryanarayana P., Saraswat M., Mrudula T., Krishna T.P., Krishnaswamy K., Reddy G.B. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 2005, 46:2092-2099.
18. Plaza S.M., Lamson D.W. Vitamin K2 in bone metabolism and osteoporosis. Altern Med Rev 2005, 10:24-35.
19. Iwasaki Y., Yamato H., Murayama H., Takhashi T., Ezwa I., Kurokawa K., et al. Menatetrenone prevents osteoblast dysfunctionbin unilateral sciatic neurectomized rats. Jpn J Pharmacol 2002, 90:88-93.
20. Natelson S. Micro-techniques of clinical chemistry for the routine laboratory 1957, 381. C. C. Thomas, Springfield, IL.
21. Fossati P., Prencipe L., Berti G. Use of 3,5-dichloro-2-hydroxy benzene sulfonic and/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980, 26:227-231.
22. Boneses R.N., Taussk H.A. On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 1954, 158:581-591.
23. Manikandan R., Thiagarajan R., Beulaja S., Sudhandiran G., Arumugam M. Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium. Free Radic Biol Med 2010, 48:483-492.
24. Manikandan R., Thiagarajan R., Beulaja S., Sudhandiran G., Arumugam M. Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups. Curr Eye Res 2010, 35:122-129.
25. Hayman S., Kinoshita J.H. Isolation and properties of lens aldose reductase. J Biochem 1964, 240:877-882.
26. 2+-ATPases from erythrocyte membrane. Biochim Biophys Acta 1983, 728:281-288.
27. Bonting S.L., Carabaggio L.L., Hawkins N.M. Studies on sodium-potassium-activated adenosine triphosphatases. VI. Its role in cation transport in the lens of cat, calf and rabbit. Arch Biochem Biophys 1963, 101:47-55.
28. Lowry O.H., Roserbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 1:265-275.
29. Cooper M.E., Bonnet F., Oldfield M., Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 2001, 14:475-486.
30. Singh D.K., Winocour P., Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 2011, 7:176-184.
31. Kanwar Y.S., Sun L., Xie P., Liu F.Y., Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 2011, 6:395-423.
32. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
33. Gill P.S., Wilcox C.S. NADPH oxidases in the kidney. Antioxid Redox Signal 2006, 8:1597-1607.
34. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005, 280:39616-39626.
35. Thallas-Bonke V., Thorpe S.R., Coughlan M.T. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway. Diabetes 2008, 57:460-469.
36. Onozato M.L., Tojo A., Goto A., Fujita T., Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002, 61:186-194.
37. Lakshmanan A.P., Watanabe K., Thandavarayan R.A., Sari F.R., Harima M., Giridharan V.V., et al. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. Free Radic Res 2011, 45:575-584.
38. Vervoot L.M., Ronde J.E., Thijssen H.H. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation. Biochem Pharmacol 1997, 54:871-876.
39. Srivastava S.K., Ramana K.V., Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005, 26:380-392.
40. Shi X., Liao S., Mi H., Guo C., Qi D., Li F., et al. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules 2012, 17:12868-12891.
41. Jaiswal N., Bhatia V., Srivastava S.P., Srivastava A.K., Tamrakar A.K. Antidiabetic effect of Eclipta alba associated with the inhibition of alpha-glucosidase and aldose reductase. Nat Prod Res 2012, 26:2363-2367.
42. Bhattacharya S., Manna P., Gachhui R., Sil P.C. D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. Toxicol Appl Pharmacol 2013, 267:16-29.
43. Veeresham C., Swetha E., Rao A.R., Asres K. In vitro and in vivo aldose reductase inhibitory activity of standardized extracts and the major constituent of Andrographis paniculata. Phytother Res 2013, 27:412-416.
44. Fekete A., Rosta K., Wagner L., Prokai A., Degrell P., Ruzicska E., et al. Na+, K+-ATPase is modulated by angiotensin II in diabetic rat kidney-another reason for diabetic nephropathy. J Physiol 2008, 586:5337-5348.
45. Lee Y.J., Lee Y.J., Han H.J. Regulatory mechanisms of N+/glucose cotransporters in renal proximal tubule cells. Kidney Int 2007, 106:S27-S35.
46. Vidotti D.B., Arnoni C.P., Maquigussa E., Boim M.A. Effect of long-term type 1 diabetes on renal sodium andwater transporters in rats. Am J Nephrol 2008, 28:107-114.
47. Pekiner D.B., Evcimen D.N., Ulusu N.N., Bali M., Karasu C. Effects of vitamin E on microsomal Ca(2+)-ATPase activity and calcium levels in streptozotocin-induced diabetic rat kidney. Cell Biochem Funct 2003, 21:177-182.
48. 2+ ATPase in congestive heart failure due to diabetes. Angiology 1993, 4:769-775.
49. Gonzalez N.J., Fernandez M.C., Fuentes M.M., Perez G.J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2001, 7:327-340.
50. Guijarro C., Egido J. Transcription factor-kappa b (NF-kappa b) and renal disease. Kidney Int 2001, 59:415-424.
51. Soetikno V., Sari F.R., Veeraveedu P.T., Thandavarayan R.A., Harima M., Sukumaran V., et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-kappab activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr Metab (Lond) 2011, 8:35.
52. Tomita N., Morishita R., Lan H.Y., Yamamoto K., Hazhizume M., Notake M., et al. In vivo administration of a nuclear transcription factor-kappab decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000, 11:1244-1252.
53. Ndisang J.F., Jadhav A. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis. Endocrinology 2014, 155:215-229.
54. Romero M.J., Yao L., Sridhar S., Bhatta A., Dou H., Ramesh G., et al. l-citrulline protects from kidney damage in type 1 diabetic mice. Front Immunol 2013, 4:480.